Upregulation of Interferon-?? and RANTES in the Cervix of HIV-1-Seronegative Women With High-Risk Behavior

Taha Hirbod(Karolinska University Hospital), Kristina Broliden(Karolinska University Hospital), Sonia Andersson(Karolinska University Hospital), Mara Manghi(Azienda Sanitaria Unità Locale di Reggio Emilia), Jakob Nilsson(Karolinska University Hospital), Jan Andersson(National Pedagogic University), Caterina Uberti‐Foppa(Vita-Salute San Raffaele University), Davide Ferrari(University of Modena and Reggio Emilia), Lucia Lopalco(Vita-Salute San Raffaele University)
JAIDS Journal of Acquired Immune Deficiency Syndromes
September 1, 2006
10.1097/01.qai.0000229016.85192.60
Cited by 40

Related Papers

Control of HIV despite the Discontinuation of Antiretroviral Therapy
|New England Journal of Medicine|1999|328
Immunization with HIV-1 gp41 Subunit Virosomes Induces Mucosal Antibodies Protecting Nonhuman Primates against Vaginal SHIV Challenges
|Immunity|2011|285
Three-step monoclonal antibody tumor targeting in carcinoembryonic antigen-positive patients.
|PubMed|1991|247
Mucosal and Plasma IgA from HIV-1-Exposed Uninfected Individuals Inhibit HIV-1 Transcytosis Across Human Epithelial Cells
|The Journal of Immunology|2000|244
Administration of the nitric oxide synthase inhibitor NG-methyl-l-arginine hydrochloride (546C88) by intravenous infusion for up to 72 hours can promote the resolution of shock in patients with severe sepsis: Results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002)*
|Critical Care Medicine|2004|196